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Childhood obesity continues to escalate worldwide and may affect left ventricular (LV) geometry 
and function. The aim of this study was to investigate the impact of obesity on prevalence of left 
ventricular hypertrophy (LVH) and diastolic dysfunction in children. In this analysis of prospectively 
collected cross‑sectional data of children between 5 and 16 years of age from randomly selected 
schools in Peru, parameters of LV geometry and function were compared according to presence or 
absence of obesity (body mass index z‑score > 2). LVH was based on left ventricular mass index (LVMI) 
adjusted for age and sex and defined by a z‑score of > 2. LV diastolic function was assessed using mitral 
inflow early‑to‑late diastolic flow (E/A) ratio, peak early diastolic tissue velocities of the lateral mitral 
annulus (E′), early diastolic transmitral flow velocity to tissue Doppler mitral annular early diastolic 
velocity (E/E′) ratio, and left atrial volume index (LAVI). Among 1023 children, 681 children (mean age 
12.2 ± 3.1 years, 341 male (50.1%)) were available for the present analysis, of which 150 (22.0%) were 
obese. LVH was found in 21 (14.0%) obese and in 19 (3.6%) non‑obese children  (padjusted < 0.001). LVMI 
was greater in obese than that in non‑obese children (36.1 ± 8.6 versus 28.7 ± 6.9 g/m2.7, p < 0.001). The 
mean mitral E/E′ ratio and LAVI were significantly higher in obese than those in non‑obese individuals 
(E/E′: 5.2 ± 1.1 versus 4.9 ± 0.8,  padjusted = 0.043; LAVI 11.0 ± 3.2 versus 9.6 ± 2.9,  padjusted = 0.001), whereas 
E′ and E/A ratio were comparable. Childhood obesity was associated with left ventricular hypertrophy 
and determinants of diastolic dysfunction.
ClinicalTrials.gov Identifier: NCT02353663.
Abbreviations
BMI  Body mass index
EF  Ejection fraction
E/A  Mitral inflow early-to-late diastolic flow ratio
E′  Peak early diastolic tissue velocities of mitral annulus
LV  Left ventricle
LVH  Left ventricular hypertrophy
LVM  Left ventricular mass
LVMI  Left ventricular mass index
LV S′  Tissue Doppler-derived peak systolic velocity of LV lateral wall
HFpEF  Heart failure with preserved ejection fraction
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RV S′  Tissue Doppler-derived peak systolic velocity at RV free wall
TAPSE  Tricuspid annular plane systolic excursion
WHO  World Health Organization
Childhood obesity has been emerging as a global epidemic in recent  decades1. Worldwide, more than 340 million 
children and adolescents aged 5–16 years are deemed overweight or  obese2. Data from a prospective cohort study 
in Sweden indicated that the mortality rate of children with obesity is three times higher than a population-based 
comparison group once they reach early  adulthood3.
Accumulating evidence suggests that obesity in early childhood may significantly affect cardiac geometry and 
 function4. Several small studies indicated differences in left ventricular (LV) mass, left atrial size and LV diastolic 
function between obese and non-obese  children5–7. In adults, hemodynamic and metabolic changes associated 
with obesity have been shown to promote the development of left ventricular hypertrophy (LVH) and impaired 
LV diastolic  function8,9, eventually leading to heart failure with preserved ejection fraction (HFpEF)10. Preva-
lence of HFpEF exceeds prevalence of heart failure with reduced ejection fraction, is less amenable to medical 
treatment, and carries a high risk of adverse outcome with a mortality rate exceeding 50% 5 years after the first 
 episode11,12. Prevention of LVH and diastolic dysfunction takes therefore center stage to mitigate progression 
to HFpEF.
Available evidence on a potential correlation between childhood obesity and prevalence of LVH and diastolic 
dysfunction is scarce. The aim of the present study was to test the hypothesis that children with obesity are at 
increased risk of LVH and diastolic dysfunction as compared with normal-weight children.
Methods
Study population. We analyzed prospectively collected clinical and echocardiographic data of children 
5–16 years of age from randomly selected schools in Arequipa, Peru. The sampling frame consisted of 457 pri-
mary and secondary schools. Forty classes from 20 schools were randomly selected using multistage sampling 
and taking into account location (urban versus rural) and administration (public or private) of the schools. All 
children attending one of the selected classes were eligible for inclusion. For the purpose of the present analysis, 
children with structural heart defects or more than mild valvular lesions, missing height or weight or missing 
echocardiographic parameters required for the assessment of LVH or diastolic function were excluded. The 
cross-sectional study was approved by the Human Research Ethics Committee of the University San Martín 
de Porres, Lima, Peru (Officio No. 48-2014-CIEI-USMP-CCM), and local authorizations were granted by the 
Regional Administrations of the Health and Education Ministries. Written informed consent for participation 
in the survey was obtained from parents or guardians, and children. All methods were performed in accordance 
with the relevant guidelines and regulations.
Data collection. Details of data acquisition and echocardiographic evaluation have been reported 
 previously13. In brief, demographic characteristics were collected using standardized interviews customized to 
the age of the children, and were followed by a focused physical examination. Transthoracic echocardiography 
was performed by a trained cardiologist with a MyLabAlpha (Esaote, Italy) portable echocardiography machine 
using a systematic acquisition protocol detailed  previously13. Recorded echocardiographic raw data was ana-
lyzed in the academic imaging core lab at Bern University Hospital by four imaging experts (ES, RK, FZ, PK) 
and in the academic imaging core lab at Cardialysis (ES, VG) in Rotterdam. All data was entered into a dedicated 
database maintained at the Clinical Trials Unit of the University of Bern, Switzerland.
Definitions. Obesity was defined according to World Health Organization (WHO) criteria for individuals 
< 19 years of age based on z-score of the body mass index (BMI). Calculation of the z-score for BMI is specified 
in the online—only “Supplemental material S1”. Obesity was defined by z-score > 2 of the BMI.
Left ventricular mass (LVM) was calculated using LV wall thickness and LV cavity size measured during 
diastole. LVM was then indexed to height, as recommended by the National High Blood Pressure Education 
Program Working Group on High Blood Pressure in Children and  Adolescents14. The calculation of LVM and left 
ventricular mass index (LVMI) is specified in the online—only “Supplemental material S1”. LVH was defined as 
any LVMI value above the 95th percentile. In children > 9 years of age, values > 40 g/m2.7 in girls and > 45 g/m2.7 
in boys were considered abnormal (i.e., > 95th percentile) because of little variation. In children ≤ 9 years of age, 
LVH was recorded if LVMI was > 95 percentile based on published  reference15. Left atrial volume was obtained 
in the apical four- and two-chamber views and indexed to the 2.7 power of height in meter. LV diastolic func-
tion was assessed by pulse-wave and tissue Doppler in the apical four-chamber view. Mitral inflow early-to-late 
diastolic flow (E/A) ratio, peak early diastolic tissue velocity at the mitral lateral annulus (E′) and early diastolic 
transmitral flow velocity to tissue Doppler mitral annular early diastolic velocity (mitral E/E′) ratio were recorded. 
Left ventricular end-diastolic volume (LVEDV) and left ventricular end-systolic volume (LVESV) were calcu-
lated using the Simpson’s biplane method of disks summation technique according to the American Society of 
Echocardiography  recommendations16. LV systolic function was expressed as ejection fraction (EF), derived from 
the LVEDV and LVESV. Additionally, tissue Doppler-derived peak systolic velocity of LV wall (LV S′) measured 
at the mitral lateral annulus was recorded. Right ventricular function was assessed with tricuspid annular plane 
systolic excursion (TAPSE) and tissue Doppler-derived peak systolic velocity at RV free wall (RV S′).
Statistical analysis. Continuous variables are presented as mean (standard deviation) or median (lower 
quartile, upper quartile) depending on the distribution and categorical variables as counts (%). Obese and non-
obese groups were compared using Chi-square test, Fisher’s exact test, Student’s t-test or Wilcoxon–Mann–Whit-
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ney test, as appropriate. For variables related to diastolic function, we additionally reported p-values adjusted 
for child age and child sex, computed using linear regression models that included age and sex as covariates. We 
also performed a propensity score matched analysis based on age and sex using ≥ 5 neighbours. Significance tests 
were two-tailed with a significance level set to 0.05. All analyses were conducted in Stata 16 (StataCorp. 2019. 
Stata Statistical Software: Release 16. College Station, TX: StataCorp LLC).
Results
Study population. Among 1023 children enrolled between April and May 2014, 342 subjects were excluded 
because of structural heart disease, incomplete echocardiographic data or missing BMI values, and 681 indi-
viduals (mean age 12.2 ± 3.1 years, 341 male (50.1%)) remained for the purpose of the present analysis (Fig. 1). 
Baseline characteristics of obese (n = 150, 22.0%) and non-obese children (n = 531, 78.0%) are summarized in 
Table 1. Obese children were younger than non-obese children (10.6 ± 2.4 years versus 12.6 ± 3.1 years, p < 0.001) 
and more commonly male (107 (71.3%) versus 234 (44.1%), p < 0.001).
Figure 1.  Study flow chart. The study flow chart illustrates the number of eligible children and the number of 
children included for the purpose of the present analysis.
Table 1.  Baseline characteristic. BMIz BMI Z-score, SD standard deviation, IQR interquartile range.
All patients (n = 681) Non-obese (BMIz ≤ 2) (n = 531) Obese (BMIz > 2) (n = 150) p-value
Age (months), mean (SD) 146 (36.7) 151 (36.9) 127 (29.0) < 0.001
Sex (male), n (%) 341 (50.1%) 234 (44.1%) 107 (71.3%) < 0.001
Height (cm), mean (SD) 142 (14.8) 144 (14.9) 138 (13.3) < 0.00
Waist circumference (cm), mean (SD) 72.3 (9.38) 70.3 (8.12) 79.4 (10.1) < 0.001
Heart rate (bpm), mean (SD) 79.4 (7.77) 79.1 (7.77) 80.2 (7.73) 0.132
Oxygen saturation (%), median (IQR) 96.0 [95.0–97.0] 96.0 [95.0–97.0] 96.0 [94.0–97.0] 0.061
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Cardiac geometry and function. Echocardiographic parameters of cardiac geometry and function are 
summarized in Table  2 Children with obesity were found to have greater relative wall thickness than non-
obese children (0.352 ± 0.069 versus 0.332 ± 0.080, p = 0.005) as well as greater LVMI (36.1 ± 8.64  g/m2.7 ver-
sus 28.7 ± 6.93 g/m2.7, p < 0.001). There was a linear correlation between LVMI and BMI z-score (Fig. 2). Left 
ventricular hypertrophy was found in 21 (14.0%) obese and in 19 (3.6%) non-obese children  (padjusted < 0.001) 
(Table 2, Fig. 3).
Systolic left and right systolic ventricular function were comparable between obese and non-obese children. 
In turn, measures of diastolic function differed significantly. Obese children had a significantly higher E/E′ ratio 
(5.18 vs. 4.93,  padjusted = 0.043) and larger left atrial volume index (LAVI) (11.0 vs 9.6 ml/m2.7;  padjusted = 0.001) 
than non-obese children; E′ and E/A ratio did not differ between the two groups (Table 2, Fig. 4). The findings 
of a propensity score matched analysis based on age and sex were consistent with the adjusted analysis (Sup-
plementary Table 1). The effect of obesity on LVH was consistent with no significant interaction according to 
sex. Similarly, there was no significant interaction in the E/E′ ratio. In contrast, the correlation between obesity 
and left atrial enlargement was particularly pronounced in girls as compared to boys (Supplementary Table 2).
Echocardiographic data stratified by presence or absence of obesity and LVH is shown in Supplementary 
Table 3. LV filling pressures as expressed by the E/E′ ratio were increased in obese children irrespective of 
Table 2.  Echocardiographic findings. Adj. p value p value adjusted for age and sex, 4C four-chamber view, 
BMIz BMI z-score, E inflow early diastolic flow velocity, E′ mitral lateral peak early diastolic tissue velocities, 
EF ejection fraction, ES end systolic, E/A inflow early-to-late diastolic flow ratio, LAVI left atrial volume index, 
LV left ventricle, LVEDD left ventricular end-diastolic diameter, LVESD left ventricular end-systolic diameter, 
LVMI left ventricular mass index, LV S′ tissue Doppler-derived peak systolic velocity of LV wall, PWTd 
posterior wall thickness (end diastolic), RV right ventricle, RV S′ tissue Doppler-derived peak systolic velocity 
at RV free wall, RWT relative wall thickness, SWTd septal wall thickness (end diastolic), sd standard deviation, 
TAPSE tricuspid annular plane systolic excursion. a Patients with > mild valvular lesions were excluded.
All children (n = 681) Non-obese (BMIz ≤ 2) (n = 531) Obese (BMIz > 2) (n = 150) p-value
p-value
adj
p-value (multiple imputation) 
(n = 905)
Cardiac geometry
LV Hypertrophy, n (%) 40 (5.87%) 19 (3.58%) 21 (14.0%) < 0.001 < 0.001 < 0.001
LVEDD (cm), mean (SD) 3.91 (0.479) 3.91 (0.492) 3.94 (0.431) 0.479
LVESD (cm), mean (SD) 2.39 (0.323) 2.40 (0.330) 2.38 (0.301) 0.576
SWTd (cm), mean (SD) 0.731 (0.157) 0.718 (0.158) 0.778 (0.144) < 0.001
PWTd (cm), mean (SD) 0.648 (0.123) 0.638 (0.123) 0.686 (0.116) < 0.001
RWT, mean (SD) 0.336 (0.078) 0.332 (0.080) 0.352 (0.069) 0.005
LVMI (g/m2.7), mean (SD) 30.4 (7.95) 28.7 (6.93) 36.1 (8.64) < 0.001
Right atrial area ES  (cm2), mean 
(SD) 10.2 (2.32) 10.1 (2.29) 10.6 (2.37) 0.021
Basal RV diameter 4C (cm), 
mean (SD) 3.07 (0.599) 3.05 (0.608) 3.14 (0.563) 0.151
Base-to-apex lenght 4C (cm), 
mean (SD) 6.22 (0.947) 6.18 (0.936) 6.36 (0.975) 0.052
Mid RV diameter 4C (cm), mean 
(SD) 2.78 (0.586) 2.76 (0.588) 2.86 (0.574) 0.196
Cardiac function
Systolic LV function
 LV S′ (cm/s), mean (SD) 12.1 (1.88) 12.2 (1.88) 12.0 (1.87) 0.202
 EF (%), mean (SD) 69.4 (6.29) 69.2 (6.28) 70.0 (6.30) 0.198
Diastolic LV function
 E/E′ ratio, mean (SD) 4.99 (0.898) 4.93 (0.845) 5.18 (1.05) 0.003 0.043 0.073
 E/E′ ≥ mean + 2 SD, n (%) 17 (2.50%) 10 (1.88%) 7 (4.67%) 0.072 0.120
LAVI (ml/m2.7), mean (SD) 9.9 (3.03) 9.6 (2.91) 11.0 (3.17) < 0.001 0.001 < 0.001
 LAVI ≥ mean + 2 SD, n (%) 17 (2.50%) 8 (1.51%) 9 (6.0%) 0.006 0.038
 E′ (cm/s), mean (SD) 20.4 (3.08) 20.5 (2.96) 20.2 (3.46) 0.347 0.277 0.8998
 E/A ratio, mean (SD) 1.77 (0.453) 1.78 (0.453) 1.77 (0.455) 0.855 0.271 0.651
RV function
 RV S′ (cm/s), mean (SD) 14.3 (1.83) 14.3 (1.86) 14.1 (1.70) 0.141
 TAPSE (cm), mean (SD) 2.12 (0.298) 2.13 (0.301) 2.09 (0.287) 0.096
Valvular heart diseasea
Mild mitral regurgitation, n (%) 10 (1.47%) 8 (1.51%) 2 (1.33%) 1.000
Mild tricuspid regurgitation, 
n (%) 93 (13.7%) 73 (13.7%) 20 (13.3%) 1.000
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presence or absence of LVH, whereas LAVI increased across a gradient from non-obese children with no LVH 
to non-obese children with LVH or obese children with no LVH, to obese children with LVH.
Measures of left ventricular geometry and function according to age categories are provided separately for 
girls and boys in Supplemental Tables 4 and 5, respectively.
Figure 2.  Relationship between left ventricular mass index and BMI z-score. The z-score of the body mass 
index (BMI) is shown on the x-axis. Left ventricular mass index (g/m2.7) is shown on the y-axis. Each grey dot 
represents one child. Grey line is the linear regression line.
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Discussion
In a representative sample of randomly selected children in the range of 5–16 years of age from a cross-sectional 
study, we found an association between obesity and both LVH and echocardiographic determinants of diastolic 
dysfunction. Obese children had greater LVM, greater E/E′ ratio, and a greater left atrial volume than non-obese 
children.The E/E′ ratio has been shown to correlate with the mean pulmonary capillary wedge pressure and the 
LV filling  pressures17. In our study, LV filling pressures were increased in children with obesity irrespective of 
evidence of LVH, whereas LAVI increased across a gradient with highest values in obese children with LVH 
(Supplementary Table 3).
We found a linear correlation of BMI z-score and LVMI and almost fourfold increased prevalence of LVH 
in obese as compared to non-obese children. Consistent with the results of a small prospective study including 
101 children with a mean age of 13.5 years, obese children were found to have a greater septal and posterior wall 
 thickness18. The impact of obesity on LV geometry may take effect at an early stage in life. Data from the Genera-
tion R Study including 974 children with longitudinal echocardiographic follow-up indicated, that overweight 
and obese children develop cardiac adaptions similar to those of obese adults as young as 2 years of  age19. In 
addition, data from the Framingham Cohort Study showed that the number of years lived with obesity is directly 
associated with the risk of  mortality20.
Echocardiographic indicators of LV diastolic function were significantly different between obese and non-
obese children in our study. In particular, we found greater LV diastolic filling pressures (E/E′) and larger left 
atrial volume in obese as compared to non-obese children. The latter finding corroborated the results of previ-
ous  reports5,18. In contrast to the study by Mangner and colleagues, we did not find differences in mitral inflow 
early-to-late diastolic flow (E/A) ratio in obese versus non-obese  children18. Evidence of the effect of LVH 
on LV diastolic dysfunction is controversial. In one study including 74 severely obese patients with a mean 
age of 37 ± 8 years, increased LVMI correlated with elevated LV filling  pressures21. However, recent evidence 
suggested an increased E/E′ ratio as an early marker of obesity cardiomyopathy in obese children even in the 
absence of LVH. In one small cross-sectional study including 32 obese and 30 non-obese children with a mean 
age of 10.6 years, obese children were found to have increased LV filling pressures as expressed by the E/E′ 
ratio (9.0 ± 1.6 versus 6.9 ± 1.4; p value = 0.001) compared to non-obese subjects even after exclusion of cases 
with  LVH22. Our findings corroborate this observation with numerically higher LV filling pressures in obese as 
compared to non-obese children irrespective of echocardiographic evidence of LVH.
The impact of obesity on LVH and diastolic dysfunction in adults is explained by hemodynamic and endo-
crinologic alterations related to  obesity23. Excessive fat tissue accumulation promotes the growth of peripheral 
blood vessels eventually resulting in an increase in cardiac output. Hemodynamic overload leads to increase 
Figure 4.  Parameters of diastolic function in obese and non-obese children. (A) E/E′ indicates the ratio 
between mitral peak velocity of early filling and peak early diastolic tissue velocities of mitral annulus. (B) Left 
atrial volume indexed to height. (C) E′ indicates peak early diastolic tissue velocities of mitral annulus. (D) E/A 
indicates the ratio between mitral peak velocity of early diastolic filling and atrial filling.
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in diastolic filling pressures, LV wall stress and  LVH24. Pericardial and intracellular fat increases heart muscle, 
stiffens the LV, and compromises diastolic  function25. Various neurohormonal and metabolic factors related 
to obesity further contribute to cardiac  remodeling26. However, the importance of these pathophysiological 
mechanisms in children is incompletely understood.
Almost all of these unfavorable alterations of LV geometry and function are responsive to weight  loss24,27,28. 
The most robust data in this context comes from clinical outcomes after bariatric surgery. Ippisch and colleagues 
reported data from 38 adolescents with a mean age of 16 years evaluated before and after bariatric surgery. After 
a mean follow up of 10 months and a substantial weight loss of 59 ± 15 kg, echocardiographic follow up showed 
a reduction of LVMI (54 ± 13 g/m2.7 to 42 ± 10 g/m2.7, p < 0.0001), a reduction in the prevalence of LVH from 28 
to 3%, and improvement in diastolic  function29. Moreover, prospective data of 62 children with a mean duration 
of follow up of 3.2 years showed normalization of global longitudinal strain after weight  reduction28.
The potential reversibility of LV dysfunction associated with obesity highlights the importance of early diag-
nosis and treatment of obesity in children. Echocardiography is currently not routinely recommended in the 
management of obese children, and is reserved for children with arterial  hypertension30–33. Implementation of 
evidence based interventions and early educational programs focused on healthy life style promotion in children 
may represent a window of opportunity to prevent HFpEF in adulthood.
The findings of the present analysis need to be interpreted in light of several limitations. First, there is no 
standard definition of diastolic dysfunction in children and adolescents. While our study indicates statisti-
cally significant differences in parameters of diastolic function, the clinical relevance of this difference remains 
unclear. Second, one third of children included into the cross-sectional study were excluded from the present 
analysis due to missing echocardiographic data; this may have introduced a selection bias of the studied cohort. 
However, an analysis using multiple imputation showed consistent results with the main findings. Third, E′ was 
measured at the lateral mitral annulus only, which may have led to an underestimation of LV filling pressures. 
Fourth, blood pressure was not prospectively recorded and may have contributed to the development of LVH 
and diastolic dysfunction. However, there is evidence suggesting that LVH and diastolic dysfunction in obese 
children are present even before the development of arterial  hypertension35. Fifth, reproducibility testing is not 
available; however, all analyses were performed in agreement with a pre-defined analysis plan following the 
left chamber quantification guidelines and with the supervision of one cardiologist (ES), reducing the risk of 
uncontrolled variability. Sixth, children were not screened for disorders of the endocrine system or chromosomal 
disorders, which may have led to confounding of our data. And finally, our study represents a cross-sectional 
survey. Longitudinal data is needed to delineate the risk of transition from subclinical diastolic dysfunction in 
childhood to HFpEF later on in life.
In conclusion, in a cross-sectional study among children, obesity was associated with increased LVM, LVH, 
increased LV filling pressures, and increased left atrial volume. Early signs of compromised diastolic function in 
obese children highlight the importance of healthy life style promotion in children.
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